Scholar Rock Holding Corporation

NasdaqGS:SRRK Stock Report

Market Cap: US$5.1b

Scholar Rock Holding Future Growth

Future criteria checks 2/6

Scholar Rock Holding is forecast to grow earnings and revenue by 45.1% and 50.4% per annum respectively. EPS is expected to grow by 47.2% per annum. Return on equity is forecast to be -14.3% in 3 years.

Key information

45.1%

Earnings growth rate

47.18%

EPS growth rate

Biotechs earnings growth23.5%
Revenue growth rate50.4%
Future return on equity-14.32%
Analyst coverage

Good

Last updated05 Mar 2026

Recent future growth updates

Recent updates

Muscle-Targeted SMA Therapies And Global Expansion Will Reshape Long-Term Outlook

Catalysts About Scholar Rock Holding Scholar Rock Holding focuses on developing muscle-targeted therapies for rare and severe neuromuscular diseases, led by its apitegromab program for spinal muscular atrophy and a broader anti myostatin pipeline. What are the underlying business or industry changes driving this perspective?

Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating

Jan 06

Scholar Rock: Apitegromab Approval And Obesity Shot Make For Rating Upgrade

Apr 17

Scholar Rock: More Than Just An SMA Biotech With Q2 2025 Obesity Treatment Data

Jan 30

Scholar Rock: Likely Approval In SMA Plus Obesity Data In 2025 Intrigue, But Price Too High

Dec 24

Scholar Rock: SMA Program Strides Forward With Positive Clinical Data

Oct 07

Scholar Rock: Solid Data And Good Prospects

Jan 12

Scholar Rock: OLE Data In SMA Coupled With New CEO Make It A Buy

Oct 20

Jay Backstrom is the new CEO at Scholar Rock

Sep 20

Scholar Rock initiated at buy at Truist on platform for rare diseases and oncology

Jul 12

Earnings and Revenue Growth Forecasts

NasdaqGS:SRRK - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2028373-176-101-9511
12/31/2027177-289-172-15514
12/31/202621-386-300-29314
12/31/2025N/A-378-301-300N/A
9/30/2025N/A-353-275-274N/A
6/30/2025N/A-316-258-258N/A
3/31/2025N/A-264-230-230N/A
12/31/2024N/A-246-201-201N/A
9/30/2024N/A-226-189-189N/A
6/30/2024N/A-204-169-169N/A
3/31/2024N/A-183-152-152N/A
12/31/2023N/A-166-145-145N/A
9/30/2023N/A-159-137-137N/A
6/30/2023N/A-160-131-131N/A
3/31/2023N/A-166-134-133N/A
12/31/202233-135-134-133N/A
9/30/202237-131-138-136N/A
6/30/202243-125-149-146N/A
3/31/202247-112-146-143N/A
12/31/202119-132-132-127N/A
9/30/202118-122-121-114N/A
6/30/202116-109-109-101N/A
3/31/202115-97-96-89N/A
12/31/202015-86-64-60N/A
9/30/202020-71-60-57N/A
6/30/202021-64-50-48N/A
3/31/202022-57-48-45N/A
12/31/201920-51-66-63N/A
9/30/201913-54N/A8N/A
6/30/20198-49N/A14N/A
3/31/20193-51N/A19N/A
12/31/2018N/A-49N/A25N/A
9/30/2018N/A-43N/A-37N/A
6/30/2018N/A-38N/A-33N/A
3/31/2018N/A-29N/A-27N/A
12/31/2017N/A-25N/A-22N/A
12/31/20160-16N/A-15N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SRRK is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SRRK is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SRRK is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SRRK's revenue (50.4% per year) is forecast to grow faster than the US market (10.4% per year).

High Growth Revenue: SRRK's revenue (50.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SRRK is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/11 21:57
End of Day Share Price 2026/03/11 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Scholar Rock Holding Corporation is covered by 22 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Madhu KumarBaird
Etzer DaroutBarclays
Evan SeigermanBMO Capital Markets Equity Research